Solr Mobile Search
Page Title - Publications and Digital Products
Publications and Digital Products
User account menu
Your browser is not supported
Switch to Chrome, Edge, Firefox or Safari
988 Separation Alert
Looking for 988 materials? Visit the new 988 ordering website.
Filters
Publication Category
Publication Primary Audience
Issues, Conditions and Disorders
Treatment, Prevention and Recovery
Professional and Research Topics
Substances
Format
Audience
Population Group
Series
Language
Dashboard: Filter Bricks
Main page content

Opioid misuse and use disorders among older adults are a growing public health problem that is often overlooked and undertreated. This increasing misuse and need for treatment can be attributed to several cultural, physiological, and systemic influences. This brochure discusses age-appropriate OUD prevention, treatment, and recovery approaches and provides key facts, considerations, program examples, and resources.

Innovative and Holistic Programs that Offer Medications for Opioid Use Disorder to Pregnant and Parenting Women Issue Brief highlights two SAMHSA-funded grant programs—E-MOMS and KS HEART—to illustrate the implementation of critical service elements for women’s Substance Use Disorder/Opioid Use Disorder (SUD/OUD) treatment in two states.

Mobile Medication Units and Health Clinics Issue Brief demonstrates how these models can provide better access in communities where obstacles to receiving care exist and can support continuity of services, thus serving an important role in addressing the opioid crisis; highlights efforts in two states; and provides recommendations and lessons learned for offering mobile services.

Medications for Opioid Use Disorder: An Effective Treatment for Justice-Involved Persons Reentering the Community Brief Reference Document explores how Opioid Use Disorder (OUD) treatment for justice-involved individuals will help lower the overdose risk for people reentering the community. It discusses treatment barriers, strategies to address them, and key reentry services to promote the successful reintegration of people returning to the community from incarceration.

The Drug Abuse Warning Network (DAWN) National Estimates from Drug-Related Emergency Department Visits, 2023 report provides weighted national estimates. The frequency of substance-related visits increased by 5.8 percent compared to estimates in 2022. Rates of all substance-related ED visits from participating hospitals were highest among individuals with the following characteristics: males (2,668 per 100,000), individuals who were not Hispanic or Latino (2,391 per 100,000), and Black individuals, after accounting for the underlying population (4,053 per 100,000 versus 1,736 per 100,000 in the next highest subpopulation). The top substances reported were alcohol, cannabis, opioids, methamphetamines, cocaine, and benzodiazepines.

This manual provides guidelines for operating an opioid treatment program. It covers patient-centered care planning, assessment, admission, and monitoring; medication administration and use; medical and clinical provisions and practices; certification and accreditation; and the importance of practitioner judgment in providing care.

This report provides important insights into the effectiveness of high-dose buprenorphine for treating opioid use disorder, especially among individuals exposed to high-potency synthetic opioids.



This guide was drawn from HEALing Communities Study (HCS) learnings to-date and expert insights to provide guidance regarding implementation of ORCCA menu strategies.
Displaying 1 - 10 out of 77